Next Article in Journal
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo
Previous Article in Journal
Clinical Management of COVID-19 in Cancer Patients with the STAT3 Inhibitor Silibinin
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(1), 20; https://doi.org/10.3390/ph15010020
Action Date Notes Link
article xml file uploaded 24 December 2021 11:46 CET Original file -
article xml uploaded. 24 December 2021 11:46 CET Update -
article pdf uploaded. 24 December 2021 11:46 CET Version of Record -
article supplementary file uploaded. 24 December 2021 11:46 CET - https://www.mdpi.com/1424-8247/15/1/20#supplementary
article html file updated 24 December 2021 11:48 CET Original file -
article xml file uploaded 24 December 2021 14:00 CET Update -
article xml uploaded. 24 December 2021 14:01 CET Update https://www.mdpi.com/1424-8247/15/1/20/xml
article pdf uploaded. 24 December 2021 14:01 CET Updated version of record https://www.mdpi.com/1424-8247/15/1/20/pdf
article html file updated 24 December 2021 14:02 CET Update -
article html file updated 31 July 2022 00:18 CEST Update https://www.mdpi.com/1424-8247/15/1/20/html
Back to TopTop